Women diagnosed with non-small cell lung cancers (NSCLC) live longer than their male counterparts, according to results of a SWOG study presented by Kathy Albain, MD, the Huizenga Family Endowed Chair in Oncology Research at Loyola University Chicago Stritch School of Medicine, at the International Association for the Study of Lung Cancer's (IASLC's) 19th World Conference on Lung Cancer (WCLC) in Toronto, Ontario, Canada.
All news from Thoracic Medicine
People suffering from two common conditions post-traumatic stress disorder (PTSD) and the breathing disorder known as a chronic obstructive pulmonary disease (COPD), may be increasing their risk for suicide if they take benzodiazepine drugs, a new study suggests.
Benzodiazepines include powerful drugs such as Ativan, Valium, and Xanax. These medications are prescribed to people with PTSD to ease anxiety, insomnia or shortness of breath. The study was published in the Annals of the American Thoracic Society.
Despite a common belief that weekend and holiday discharge after major heart surgery may impact hospital readmissions. The study was published online in The Annals of Thoracic Surgery showed that the day of discharge does not affect readmissions.
Because the rate of rehospitalization after major cardiac surgery has been reported up to 22%, an investigation of potentially modifiable elements in the discharge process has led our group to determine whether the day of discharge affects readmission performance.
The new retrospective review of 17 patients with thoracic scoliosis who underwent previous spinal growth tethering (ASGT) has shed light on the subtleties involved in this technique. The study, " Previous Spinal Growth Tethering for Skeletally Immature Patients with Scoliosis: A Retrospective Look Two to Four Years Postoperatively," appears in the October 3, 2018 edition of The Journal of Bone and Joint Surgery.
How long a person with obstructive sleep apnea (OSA) stops breathing may be a better predictor of mortality risk from OSA than the number of times they stop breathing, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
Representing paradigm shift in thoracic surgery, the hybrid operating room combines three techniques into a single appointment eliminating multiple clinical visits for improved patient experience and outcomes.
Patients with metastatic NSCLC receiving treatment at academic centers (ACs) have an increased 2-year survival compared to patients treated at community-based centers (CCs). An overall histology-dependent survival was also noted in patients with adenocarcinoma verses squamous cell carcinoma and varied by treatment facility.
TB Alliance has initiated a pivotal clinical trial, SimpliciTB (pronounced: sim-plis-i-tee-bee), that will evaluate whether a new four-drug regimen can treat most types of tuberculosis (TB) including multidrug-resistant TB (MDR-TB) more quickly and effectively than currently-available treatments.
The first patients have been enrolled at the National Center for Tuberculosis and Lung Disease in Tbilisi, Georgia. SimpliciTB is expected to enroll 450 people with TB, including up to 150 with MDR-TB across at least 26 centers in 10 countries in Africa, Asia, Europe and Latin America.
Abnormal levels of more than two dozen metabolites—chemicals produced in the body as it breaks down fats, proteins and carbohydrates—can reliably predict which Sept. 11 firefighters developed lung disease and which did not, a new analysis shows.
Children's growth in the first three years of life affects the development of their lungs and the risk of asthma at 10 years of age. This is the main conclusion of a new study carried out by the Barcelona Institute for Global Health (ISGlobal), a centre supported by the "la Caixa" Banking Foundation, and Erasmus University Medical Centre in Rotterdam, The Netherlands.
Of the more than 24 million people in the U.S. who have asthma, 10% have severe asthma—a form of the disease that does not respond to treatment. The immunological mechanisms underlying severe asthma and asthmatic lung inflammation are not well understood.
A new study by investigators from Brigham and Women's Hospital published this week in Science Immunology models allergic lung inflammation and provides new insights into how asthma develops and progresses, with important implications for the most clinically advanced drugs designed to treat severe asthma.
Tuberculosis is one of the world's deadliest infectious disease. Worldwide, there are still about 10.4 million cases of TB and 1.7 million deaths every year. One of the reasons it's been hard to bring the disease under control is that the drugs used to treat it require a gruelling regimen and can be toxic. This means people very often don't finish the course.